Download | < Back |
08 May 2021 | |
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose a communication pertaining to favorable ruling received by Jubilant Pharma Limited, Singapore, a subsidiary of the Company from the United States Court of Appeals regarding Jubilant's RUBY-FILL?? Generator and RUBY Rubidium Elution System???. | |
View all announcements for Jubilant Pharmova Ltd | Source: BSE India |